Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

# AGENCY:

National Institutes of Health, HHS.

# ACTION:

Notice.

# SUMMARY:

The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on March 8, 2022. The topic for this meeting will be “Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.” The meeting is open to the public.

# DATES:

The meeting will be held on March 8, 2022 from 8:30 a.m. to 4:45 p.m. EDT.

# ADDRESSES:

                        The meeting will be held via an online video conferencing platform. Virtual attendance for the meeting will be accessible to members of the public who register at                         *https://www.scgcorp.com/​dmicc2022/​Registration*                         at least 5 days prior to the workshop.                    

# FOR FURTHER INFORMATION CONTACT:

                        For further information concerning this meeting, including a draft agenda, which will be posted when available, see the DMICC website,                         *www.diabetescommittee.gov,*                         or contact Dr. William Cefalu, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Democracy 2, Room 6037, Bethesda, MD 20892, telephone: 301-435-1011; email:                         *dmicc@mail.nih.gov.*

# SUPPLEMENTARY INFORMATION:

In accordance with 42 U.S.C. 285c-3, the DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The March 8, 2022 DMICC meeting will focus on “Opportunities for Research Supported by the Special Statutory Funding Program for Type 1 Diabetes Research.” Any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, there will not be time on the agenda for oral comments from members of the public.

                    Members of the public who would like to receive email notification about future DMICC meetings should register for the listserv available on the DMICC website,                     *www.diabetescommittee.gov.*

Dated: January 19, 2022.

Bruce Tibor Roberts,

Executive Secretary, DMICC, Office of Scientific Program and Policy Analysis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

[FR Doc. 2022-01345 Filed 1-24-22; 8:45 am]

BILLING CODE 4140-01-P